Literature DB >> 20393732

[Pterygium. Etiology, clinical aspects and novel adjuvant therapies].

L M Heindl1, C Cursiefen.   

Abstract

Pterygium is a common UV-induced degeneration of the limbal conjunctiva. Indications for surgery include loss of visual acuity, increasing astigmatism, impending invasion of the optical axis and ocular surface discomfort. Measures to reduce the risk of recurrence include 1. an optimal surgical strategy (intra-operative use of antimetabolites and free conjunctival graft), 2. postoperative topical therapy with steroids and lubricants free of preservatives and 3. long-term UV protection. Novel anti-angiogenic treatment approaches for prevention of recurrence of pterygium are discussed.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20393732     DOI: 10.1007/s00347-009-2100-4

Source DB:  PubMed          Journal:  Ophthalmologe        ISSN: 0941-293X            Impact factor:   1.059


  28 in total

Review 1.  The treatment of pterygium.

Authors:  Lawrence W Hirst
Journal:  Surv Ophthalmol       Date:  2003 Mar-Apr       Impact factor: 6.048

2.  [Bevacizumab goes anterior: antiangiogenic therapy at cornea and conjunctiva].

Authors:  C Cursiefen
Journal:  Ophthalmologe       Date:  2009-05       Impact factor: 1.059

3.  Pterygium and associated ocular surface squamous neoplasia.

Authors:  Lawrence W Hirst; Roy A Axelsen; Ivan Schwab
Journal:  Arch Ophthalmol       Date:  2009-01

Review 4.  Current concepts and techniques in pterygium treatment.

Authors:  Leonard P K Ang; Jocelyn L L Chua; Donald T H Tan
Journal:  Curr Opin Ophthalmol       Date:  2007-07       Impact factor: 3.761

5.  Pterygium and ultraviolet radiation: a positive correlation.

Authors:  D J Moran; F C Hollows
Journal:  Br J Ophthalmol       Date:  1984-05       Impact factor: 4.638

6.  Postoperative subconjunctival corticosteroid injection to prevent pterygium recurrence.

Authors:  Fabiana dos Santos Paris; Charles Costa de Farias; Gustavo Barreto Melo; Myrna Serapião Dos Santos; Jefferson Luiz Alves Batista; José Alvaro Pereira Gomes
Journal:  Cornea       Date:  2008-05       Impact factor: 2.651

7.  The effect of topical bevacizumab on corneal neovascularization.

Authors:  Sang Woo Kim; Byung Jin Ha; Eung Kweon Kim; Hungwon Tchah; Tae-im Kim
Journal:  Ophthalmology       Date:  2008-04-24       Impact factor: 12.079

8.  Prospective study on the safety and efficacy of combined conjunctival rotational autograft with intraoperative 0.02% mitomycin C in primary pterygium excision.

Authors:  Alvin L Young; Patrick M K Tam; Gloria Y S Leung; Lulu L Cheng; Philip T H Lam; Dennis S C Lam
Journal:  Cornea       Date:  2009-02       Impact factor: 2.651

9.  [Antiangiogenic therapy for pterygium recurrence].

Authors:  S Leippi; F Grehn; G Geerling
Journal:  Ophthalmologe       Date:  2009-05       Impact factor: 1.059

10.  Bevacizumab (Avastin) eye drops inhibit corneal neovascularization.

Authors:  Felix Bock; Yanyan König; Friedrich Kruse; Martin Baier; Claus Cursiefen
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2007-10-13       Impact factor: 3.117

View more
  7 in total

Review 1.  [Operative techniques for surgical treatment of primary and recurrent pterygia].

Authors:  W Sekundo; K Droutsas; C Cursiefen
Journal:  Ophthalmologe       Date:  2010-06       Impact factor: 1.059

2.  Post-trabeculectomy topical bevacizumab preventing bleb failure: a preliminary study.

Authors:  Shashi Kumar Bhasker; Sandeep Saxena; Kamlesh Singh
Journal:  J Ocul Biol Dis Infor       Date:  2013-06-27

3.  Ocular diseases in metastatic cutaneous melanoma: review of 108 consecutive patients in two German tertiary centers.

Authors:  Rafael S Grajewski; Beatrice Schuler-Thurner; Cornelia Mauch; Nicole Kreuzberg; Konrad R Koch; Antonio Bergua; Claus Cursiefen; Ludwig M Heindl
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2014-01-22       Impact factor: 3.117

4.  [Pterygium and pinguecula].

Authors:  Alexander C Rokohl; Ludwig M Heindl; Claus Cursiefen
Journal:  Ophthalmologe       Date:  2021-09-20       Impact factor: 1.059

5.  [Pterygium: pathogenesis, diagnosis and treatment].

Authors:  Alexander C Rokohl; Ludwig M Heindl; Claus Cursiefen
Journal:  Ophthalmologe       Date:  2021-03-29       Impact factor: 1.059

6.  [Pterygium: what about point of care biomarkers?]

Authors:  Alexander C Rokohl; Ludwig M Heindl; Claus Cursiefen
Journal:  Ophthalmologe       Date:  2021-05-31       Impact factor: 1.059

7.  [Double vision in a 60-year-old male patient].

Authors:  Amine Maamri; Shady Suffo; Barbara Käsmann-Kellner; Berthold Seitz
Journal:  Ophthalmologe       Date:  2021-06-10       Impact factor: 1.059

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.